Loading...

Eisai Co., Ltd.

ESALY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$61.51
$-1.33(-2.11%)

Eisai Co., Ltd. (ESALY) Stock Overview

Explore Eisai Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.4/100

Key Financials

Market Cap17.6B
P/E Ratio56.50
EPS (TTM)$3.00
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$110.97

ESALY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eisai Co., Ltd. (ESALY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $110.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 56.50 and a market capitalization of 17.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;